FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Pierce David A
2. Issuer Name and Ticker or Trading Symbol

BOSTON SCIENTIFIC CORP [ BSX ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
EVP Pres MedSurg
(Last)          (First)          (Middle)

300 BOSTON SCIENTIFIC WAY
3. Date of Earliest Transaction (MM/DD/YYYY)

2/21/2020
(Street)

MARLBOROUGH, MA 01752-1234
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 2/21/2020  M  2492.0000 A$0.0000 (1)35032.0000 D  
Common Stock 2/21/2020  F  1132.0000 D$42.6200 33900.0000 D  
Common Stock 2/22/2020  M  2607.0000 A$0.0000 (1)36507.0000 D  
Common Stock 2/22/2020  F  1184.0000 D$42.6200 35323.0000 D  
Common Stock 2/23/2020  M  2453.0000 A$0.0000 (1)37776.0000 D  
Common Stock 2/23/2020  F  1114.0000 D$42.6200 36662.0000 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Deferred Stock Units  (1)2/21/2020  M     2492.0000   (2)2/21/2023 (2)Common Stock 2492.0000 $0.0000 7478.0000 D  
Deferred Stock Units  (1)2/22/2020  M     2607.0000   (3)2/22/2021 (3)Common Stock 2607.0000 $0.0000 2607.0000 D  
Deferred Stock Units  (1)2/23/2020  M     2453.0000   (4)2/23/2020 (4)Common Stock 2453.0000 $0.0000 0.0000 D  

Explanation of Responses:
(1) Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
(2) Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.
(3) Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
(4) Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Pierce David A
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH, MA 01752-1234


EVP Pres MedSurg

Signatures
/s/ Scott G. Hodgdon, Attorney-in-Fact2/24/2020
**Signature of Reporting PersonDate

Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Boston Scientific Charts.
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Boston Scientific Charts.